{"product_id":"global-dna-next-generation-sequencing-market-growth-status-and-outlook-2023-2029","title":"Global DNA Next Generation Sequencing Market Growth (Status and Outlook) 2023-2029","description":"\u003cp\u003eGlobal DNA Next Generation Sequencing Market Growth (Status and Outlook) 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eNext-generation sequencing (NGS), also known as high-throughput sequencing, is the catch-all term used to describe a number of different modern sequencing technologies.\u003c\/p\u003e\n\n\u003cp\u003eLPI (LP Information)' newest research report, the “DNA Next Generation Sequencing Industry Forecast” looks at past sales and reviews total world DNA Next Generation Sequencing sales in 2022, providing a comprehensive analysis by region and market sector of projected DNA Next Generation Sequencing sales for 2023 through 2029. With DNA Next Generation Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DNA Next Generation Sequencing industry.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report provides a comprehensive analysis of the global DNA Next Generation Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on DNA Next Generation Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DNA Next Generation Sequencing market.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DNA Next Generation Sequencing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DNA Next Generation Sequencing.\u003c\/p\u003e\n\n\u003cp\u003eThe global DNA Next Generation Sequencing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.\u003c\/p\u003e\n\n\u003cp\u003eUnited States market for DNA Next Generation Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.\u003c\/p\u003e\n\n\u003cp\u003eChina market for DNA Next Generation Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.\u003c\/p\u003e\n\n\u003cp\u003eEurope market for DNA Next Generation Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.\u003c\/p\u003e\n\n\u003cp\u003eGlobal key DNA Next Generation Sequencing players cover Illumina, Roche, Pacific Biosciences, BGI, Thermo Fisher Scientific, Qiagen, PerkinElmer, Agilent Technologies and Bio-Rad, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.\u003c\/p\u003e\n\n\u003cp\u003eThis report presents a comprehensive overview, market shares, and growth opportunities of DNA Next Generation Sequencing market by product type, application, key players and key regions and countries.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by type\u003cbr\u003e\nConsumables\u003cbr\u003e\nInstruments\u003cbr\u003e\nServices\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by application\u003cbr\u003e\nHospitals and Clinics\u003cbr\u003e\nAcademic \u0026amp; Research Institutes\u003cbr\u003e\nPharmaceutical \u0026amp; Biotechnology Companies\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eThis report also splits the market by region:\u003cbr\u003e\nAmericas\u003cbr\u003e\nUnited States\u003cbr\u003e\nCanada\u003cbr\u003e\nMexico\u003cbr\u003e\nBrazil\u003cbr\u003e\nAPAC\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nKorea\u003cbr\u003e\nSoutheast Asia\u003cbr\u003e\nIndia\u003cbr\u003e\nAustralia\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nUK\u003cbr\u003e\nItaly\u003cbr\u003e\nRussia\u003cbr\u003e\nMiddle East \u0026amp; Africa\u003cbr\u003e\nEgypt\u003cbr\u003e\nSouth Africa\u003cbr\u003e\nIsrael\u003cbr\u003e\nTurkey\u003cbr\u003e\nGCC Countries\u003c\/p\u003e\n\n\u003cp\u003eThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\nIllumina\u003cbr\u003e\nRoche\u003cbr\u003e\nPacific Biosciences\u003cbr\u003e\nBGI\u003cbr\u003e\nThermo Fisher Scientific\u003cbr\u003e\nQiagen\u003cbr\u003e\nPerkinElmer\u003cbr\u003e\nAgilent Technologies\u003cbr\u003e\nBio-Rad\u003cbr\u003e\nEurofins Scientific\u003cbr\u003e\nNatera\u003cbr\u003e\nLabCorp\u003cbr\u003e\nMacrogen\u003cbr\u003e\nNovo Gene\u003cbr\u003e\nWuXi AppTec\u003cbr\u003e\nBerry Genomics\u003cbr\u003e\nBrooks Life Sciences\u003cbr\u003e\nPersonalis\u003cbr\u003e\nGenotypic Technology\u003cbr\u003e\nDna Link\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"March, 2023 \/ 121 Pages \/ MCW16228577","offer_id":47646867980594,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-dna-next-generation-sequencing-market-growth-status-and-outlook-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}